Skip to content

Clinical trials

Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Clear all

1,286 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
200118
200215
200318
200424
200526
200635
200741
200845
200957
201040
201133
201243
201339
201440
201551
201643
201760
201853
201959
202061
202166
202268
202375
202479
202566
202670

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed548
Unknown status228
Recruiting194
Terminated131
Active, not recruiting62
Not yet recruiting55
Withdrawn49
Enrolling by invitation10
No longer available4
Suspended3
Approved for marketing2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)34
M.D. Anderson Cancer Center23
Memorial Sloan Kettering Cancer Center22
Sun Yat-sen University21
National Institutes of Health Clinical Center (CC)16
Bayer15
National Taiwan University Hospital15
Fuda Cancer Hospital, Guangzhou13
Massachusetts General Hospital12
Stanford University12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms1,286
Carcinoma, Hepatocellular522
Pancreatic Neoplasms179
Stomach Neoplasms144
Colorectal Neoplasms138
Lung Neoplasms123
Neoplasms115
Breast Neoplasms104
Neoplasm Metastasis103
Esophageal Neoplasms101

Trials

Showing 26 to 50 of 1,286. Each trial links to its page on Pharma Observatory.

1,186 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.